ERG and prostate carcinoma: Mumtaz et al. found that the expression of mir-4482 was decreased in prostate cancer tissues when compared with the adjacent normal tissues and could inhibit the progression of prostate cancer cells by suppressing the expression of ETS-related gene [32].